Robaei, Daniel <br/><br/>
Twelve-Month Outcomes With a Bioresorbable Everolimus-Eluting Scaffold: Results of the ESHC-BVS Registry at Two Australian Centers.  [electronic resource] 

 -  The Journal of invasive cardiology  Aug 2016 
 - 316-22 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1557-2501 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Absorbable Implants--adverse effects<br/>Aged<br/>Australia--epidemiology<br/>Coronary Angiography--methods<br/>Coronary Artery Disease--diagnosis<br/>Drug-Eluting Stents--adverse effects<br/>Female<br/>Humans<br/>Incidence<br/>Male<br/>Middle Aged<br/>Outcome and Process Assessment, Health Care<br/>Percutaneous Coronary Intervention--adverse effects<br/>Postoperative Complications--classification<br/>Prosthesis Design<br/>Registries<br/>Tissue Scaffolds--statistics & numerical data